Tag : AGE-RELATED MACULAR DEGENERATION

  • CONFERENCE UPDATE
    Psoriasis associated with increased risk of AMD: Evidence from a retrospective observational cohort study

    A retrospective cohort study found that psoriasis patients aged 55 and older had a higher risk of age-related macular degeneration (AMD) compared to matched controls, suggesting the need for vigilant screening for ocular comorbidities in psoriasis management and the potential impact of lipid dysregulation on AMD progression.

  • NEWS AND PERSPECTIVE
    HCTM-UKM marks World Retina Day with focus on AMD and DME

    In an interview with Dr. Ayesha Mohd Zain and Dr. Wan Nur Najwa Wan Zakaria further shared their clinical insights on the management of age-related macular degeneration (AMD) and diabetic macular edema (DME).

    doctor name

    Dr. Wan Nur Najwa Wan Zakaria

    Trainee Ophthalmologist, Department of Ophthalmology, Hospital Canselor Tuanku Muhriz UKM (HCTM-UKM), Kuala Lumpur, Malaysia

    doctor name

    Dr. Ayesha Mohd Zain

    Head of Medical Retina Unit, Department of Ophthalmology, Hospital Canselor Tuanku Muhriz UKM (HCTM-UKM), Kuala Lumpur, Malaysia

  • NEWS AND PERSPECTIVE
    Photoactivatable nanosystem combining PDT and VEGF inhibition: A potentially safe and effective intravenous wAMD therapy

    Current treatments for wet age-related macular degeneration (wAMD) include the use of vascular endothelial growth factor (VEGF) inhibitors and the use of photodynamic therapy (PDT). Combination of these therapies may offer significant improvements in visual acuity but safety concerns remain. Researchers from the University of Hong Kong Faculty of Medicine (HKUMed) reported the development of a novel and minimally invasive approach to wAMD treatment, by intravenously administering a photoactivatable nanosystem and irradiating the diseased eyes.